EudraVigilance lists more than 2.26 million reports of adverse reactions after Covid vaccination
EudraVigilance now lists 2,260,686 adverse reaction cases reported after the administration of Covid vaccines in Europe. The data is up to August 23, 2023.
The database lists 1,234,922 individual cases up to August 23 for the Pfizer-BioNTech vaccine tozinameran. Most are from Germany (219,420), followed by France (129,884), and the Netherlands (125,842).
A total 6,039 cases are listed for the Pfizer-BioNTech bivalent booster vaccine (tozinameran, riltozinameran) that targets the original strain of SARS-CoV-2, which is no longer circulating, and the Omicron BA.1 subvariant, which has been de-escalated by the European Centre for Disease Prevention and Control. Most cases are from the Netherlands (2,216), followed by Belgium (372), and Germany (241).
A total 9,343 cases are listed for the Pfizer-BioNTech bivalent booster vaccine (tozinameran, famtozinameran) that targets the original strain of SARS-CoV-2 and the Omicron BA.4 and BA.5 subvariants. Most cases are from Germany (1,433), followed by Spain (1,101), and France (758).
A total 549,364 cases are listed for the AstraZeneca-Oxford vaccine with the most listed in Germany (54,857), followed by Austria (41,289), and the Netherlands (38,026).
A total 379,136 cases are listed for the Moderna vaccine (elasomeran). Most are from Germany (65,947), followed by the Netherlands (49,916), and France (34,363).
A total 7,859 cases are listed for the Moderna bivalent booster vaccine (elasomeran, imelasomeran) that targets the original strain of SARS-CoV-2 and the BA.1 subvariant. Most are from the Netherlands (3,616), followed by Spain (73), and France (56).
A total 667 cases are listed for the Moderna bivalent booster vaccine (elasomeran, davesomeran) that targets the original strain of SARS-CoV-2 and the Omicron BA.4 and BA.5 subvariants. Twenty-three cases are listed for Germany, 19 for France, and 12 for Norway, along with ten cases in Ireland, nine in Italy, and four in the Netherlands, but further data for individual countries is not provided.
A total 71,316 cases are listed for the Janssen Biotech vaccine. Most are from the Netherlands (15,103), followed by Germany with 12,163, and Austria (11,213).
A total 1,633 cases are now listed for the Novavax vaccine. Most are from Germany (1,007), followed by Italy with 159 cases, and France with 122.
A total 34 cases are listed for the Valneva vaccine. Eighteen cases are listed for Germany, 11 for Austria, and five for Italy.
A total 373 cases are reported for the VidPrevtyn Beta vaccine, developed by Sanofi Pasteur. Nine cases were reported in France, but the location of the other cases isn’t given.
The European Medicines Agency (EMA) states on its website that, by the end of May 2023, there had been nearly 1.7 million “spontaneous reports of suspected side effects, which translates into about 0.2 spontaneous reports for every 100 administered vaccine doses”.
It adds that there had been nearly 12,000 “spontaneous reports of fatal outcomes in the EU and EEA, which translates into about 0.001 reported fatal outcomes for every 100 administered vaccine doses”.
Nearly 768 million Covid vaccine doses had been administered in European Union and European Economic Area countries by the end of May 2023, the EMA added.
There is more detail about these statistics on my Changing Times website along with data from other adverse event databases.
The World Health Organisation updates its VigiBase data every Sunday.
The EudraVigilance data are usually updated on Mondays.
EudraVigilance doesn’t give a total of deaths reported after administration of each of the Covid-19 vaccines authorised for use in Europe, or a combined total. These figures can only be obtained by selecting reaction group categories, such as cardiac disorders, and adding up all the individual totals.
It also doesn’t give a total of adverse reaction reports; my 2,260,686 figure was obtained by adding up the totals for each individual vaccine.
See my August 26 Substack article for the latest VAERS data.